The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALLERGAN PLC | COM | G0177J908 | 10,501 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
| CASCADIAN THERAPEUTICS INC | COM | 14740B901 | 447 | 103,800 | SH | Call | SOLE | 103,800 | 0 | 0 | |
| ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 19,748 | 975,700 | SH | SOLE | 975,700 | 0 | 0 | ||
| GALAPAGOS NV | SPONSORED ADR | 36315X101 | 36,032 | 561,341 | SH | SOLE | 561,341 | 0 | 0 | ||
| NABRIVA THERAPEUTICS AG | SPONSORED ADR | 62957M104 | 1,578 | 264,773 | SH | SOLE | 264,773 | 0 | 0 | ||
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 11,236 | 414,000 | SH | SOLE | 414,000 | 0 | 0 | ||
| ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 2,536 | 874,447 | SH | SOLE | 874,447 | 0 | 0 | ||
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 972 | 23,300 | SH | SOLE | 23,300 | 0 | 0 | ||
| ALEXION PHARMACEUTICALS INC | COM | 015351109 | 19,845 | 162,200 | SH | SOLE | 162,200 | 0 | 0 | ||
| ARDELYX INC | COM | 039697107 | 18,602 | 1,310,023 | SH | SOLE | 1,310,023 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 35,759 | 2,943,164 | SH | SOLE | 2,943,164 | 0 | 0 | ||
| ATARA BIOTHERAPEUTICS INC | COM | 046513107 | 3,065 | 215,812 | SH | SOLE | 215,812 | 0 | 0 | ||
| ATYR PHARMA INC | COM | 002120103 | 2,101 | 976,986 | SH | SOLE | 976,986 | 0 | 0 | ||
| BIOPHARMX CORP | COM | 09072X101 | 502 | 1,342,000 | SH | SOLE | 1,342,000 | 0 | 0 | ||
| BRISTOL MYERS SQUIBB CO | COM | 110122108 | 500 | 8,560 | SH | SOLE | 8,560 | 0 | 0 | ||
| CHEMOCENTRYX INC | COM | 01683L106 | 873 | 118,000 | SH | SOLE | 118,000 | 0 | 0 | ||
| CHIMERIX INC | COM | 16934W106 | 6,512 | 1,415,687 | SH | SOLE | 1,415,687 | 0 | 0 | ||
| CYTOKINETICS INC | COM | 23282W605 | 667 | 54,879 | SH | SOLE | 54,879 | 0 | 0 | ||
| DERMIRA INC | COM | 24983L104 | 1,310 | 43,200 | SH | SOLE | 43,200 | 0 | 0 | ||
| EDITAS MEDICINE INC COM | COM | 28106W103 | 10,172 | 626,762 | SH | SOLE | 626,762 | 0 | 0 | ||
| EGALET CORP | COM | 28226B104 | 1,701 | 222,300 | SH | SOLE | 222,300 | 0 | 0 | ||
| FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 14,968 | 298,712 | SH | SOLE | 298,712 | 0 | 0 | ||
| IRONWOOD PHARMACEUTICALS INC | COM | 46333X108 | 43,661 | 2,855,515 | SH | SOLE | 2,855,515 | 0 | 0 | ||
| KINDRED BIOSCIENCES INC | COM | 494577109 | 2,427 | 571,126 | SH | SOLE | 571,126 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 15,410 | 2,611,906 | SH | SOLE | 2,611,906 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 1,964 | 273,862 | SH | SOLE | 273,862 | 0 | 0 | ||
| SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 773 | 63,596 | SH | SOLE | 63,596 | 0 | 0 | ||
| XENCOR INC | COM | 98401F105 | 9,870 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | ||
| FATE THERAPEUTICS INC | COM | 311900954 | 6,368 | 2,537,026 | SH | SOLE | 2,537,026 | 0 | 0 | ||
| THERAVANCE BIOPHARMA INC | NOTE | 88339KAA0 | 19,327 | 17,000,000 | PRN | SOLE | 17,000,000 | 0 | 0 | ||